X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (43) 43
index medicus (42) 42
endocrinology & metabolism (35) 35
female (24) 24
male (24) 24
middle aged (23) 23
adult (20) 20
medicine & public health (16) 16
acromegaly (14) 14
tumors (14) 14
diabetes (13) 13
transsphenoidal surgery (13) 13
aged (11) 11
human physiology (11) 11
surgery (11) 11
treatment outcome (11) 11
acromegaly - drug therapy (10) 10
retrospective studies (9) 9
somatostatin - analogs & derivatives (9) 9
young adult (9) 9
care and treatment (8) 8
clinical neurology (8) 8
endocrinology (8) 8
diagnosis (7) 7
growth-hormone (7) 7
management (7) 7
mortality (7) 7
pasireotide (7) 7
somatostatin analogs (7) 7
adenoma - drug therapy (6) 6
health aspects (6) 6
octreotide (6) 6
octreotide - therapeutic use (6) 6
pituitary (6) 6
pituitary neoplasms - surgery (6) 6
somatostatin - therapeutic use (6) 6
acromegaly - blood (5) 5
acth (5) 5
adenoma - pathology (5) 5
adenoma - surgery (5) 5
adolescent (5) 5
aged, 80 and over (5) 5
corticosteroids (5) 5
cushing's disease (5) 5
cushing’s disease (5) 5
evidence-based medicine (5) 5
hyperglycemia (5) 5
medical therapy (5) 5
prospective studies (5) 5
somatostatin (5) 5
somatotropin (5) 5
therapy (5) 5
adenoma - blood (4) 4
adenoma - complications (4) 4
adrenocorticotropic hormone (4) 4
combined modality therapy (4) 4
consensus (4) 4
cortisol (4) 4
endocrinology - methods (4) 4
expression (4) 4
follow-up (4) 4
growth hormone (4) 4
human growth hormone - blood (4) 4
hydrocortisone - blood (4) 4
insulin-like growth factor i - metabolism (4) 4
long-term treatment (4) 4
pegvisomant (4) 4
pituitary neoplasms - complications (4) 4
remission induction (4) 4
risk factors (4) 4
secretion (4) 4
som230 (4) 4
somatostatin - administration & dosage (4) 4
systematic review (4) 4
abridged index medicus (3) 3
acromegaly - diagnosis (3) 3
acromegaly - etiology (3) 3
acromegaly - metabolism (3) 3
acromegaly - surgery (3) 3
adenoma (3) 3
adenoma - diagnosis (3) 3
adrenal glands (3) 3
adrenal insufficiency - diagnosis (3) 3
adrenocorticotropic hormone - blood (3) 3
clinical-practice (3) 3
delayed-action preparations (3) 3
diabetes mellitus (3) 3
disease (3) 3
dopamine agonists (3) 3
endocrine (3) 3
endocrinology - trends (3) 3
experience (3) 3
growth hormone-secreting pituitary adenoma - drug therapy (3) 3
growth hormone-secreting pituitary adenoma - pathology (3) 3
growth-factor-i (3) 3
hormone antagonists - adverse effects (3) 3
hormones (3) 3
hyperprolactinemia (3) 3
insulin-like growth factors (3) 3
ketoconazole (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Endocrinology and Metabolism Clinics of North America, ISSN 0889-8529, 12/2016, Volume 45, Issue 4, pp. xiii - xiv
Journal Article
Endocrinology and Metabolism Clinics of North America, ISSN 0889-8529, 03/2015, Volume 44, Issue 1, pp. xxi - xxiii
Journal Article
Journal Article
European Journal of Endocrinology, ISSN 0804-4643, 06/2015, Volume 172, Issue 6, pp. 707 - 713
Journal Article
BMC Endocrine Disorders, ISSN 1472-6823, 01/2016, Volume 16, Issue 1, p. 16
Journal Article
Endocrine, ISSN 1355-008X, 8/2014, Volume 46, Issue 3, pp. 577 - 584
Journal Article
Endocrinology and Metabolism Clinics of North America, ISSN 0889-8529, 12/2017, Volume 46, Issue 4, pp. xiii - xv
Journal Article
Drug Design, Development and Therapy, ISSN 1177-8881, 01/2016, Volume 10, pp. 227 - 239
Morbidity and mortality rates in patients with active acromegaly are higher than the general population. Adequate biochemical control restores mortality to... 
Somatostatin analogs | Growth hormone | Pasireotide | Insulin-like growth factor 1 | Somatostatin receptor ligand | Emerging treatments | MORTALITY | SOM230 | CHEMISTRY, MEDICINAL | somatostatin analogs | pasireotide | ORAL OCTREOTIDE | emerging treatments | somatostatin receptor ligand | PITUITARY-ADENOMAS | SOMATOSTATIN RECEPTOR INTERNALIZATION | GROWTH-HORMONE | MEDICAL THERAPY | MULTIMODAL THERAPY | PHARMACOLOGY & PHARMACY | growth hormone | SECRETION | insulin-like growth factor 1 | PHASE-I | Acromegaly - drug therapy | Somatostatin - analogs & derivatives | Animals | Somatostatin - adverse effects | Humans | Drug Design | Somatostatin - administration & dosage | Acromegaly - physiopathology | Octreotide | Somatostatin - therapeutic use | Delayed-Action Preparations | Drug Delivery Systems | Acromegaly | Somatotropin | Care and treatment | Health aspects | Mortality | Diabetes therapy | Therapy | Cardiac arrhythmia | Nuclear magnetic resonance--NMR | Peptides | Medical services | Amino acids | Sleep apnea | Insulin-like growth factors | Kinases | Cancer therapies | Proteins | Hyperglycemia | Surgery | Somatostatin | Growth factors | Hypertension | Diabetes mellitus | Shrinkage | FDA approval | Metabolism | Insulin | Disease control | Patients | Morbidity | Ligands | Insulin resistance | Growth hormones | Diabetes | Endocrinology | Tumors
Journal Article
Pituitary, ISSN 1386-341X, 4/2018, Volume 21, Issue 2, pp. 109 - 110
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s11102-018-0875-5 
Medicine & Public Health | Human Physiology | Diabetes | ENDOCRINOLOGY & METABOLISM | Resveratrol | Pituitary
Journal Article